hi arou011. my initial reaction to the timing was like yours. While I havent confirmed the position it sounds reasonable to me that stringent conditions would apply to the $4.5million grant. The providers of the grant need certainty of process as do the hospitals and patients in the ovarian cancer trial.
I certainly take note of your posts and in fact still go over the one where you mapped out the performance of CVac based on the interim results data.
We are travelling on the same boat and I wish you well.
hi arou011. my initial reaction to the timing was like yours....
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $469.0M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $811.5K | 2.553M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 132108 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 420431 | 37 |
View Market Depth
| Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |